|
Group Post |
Recent flooding in Maryland showes the need for stronger resilience planning |
mike kraft |
|
Group Post |
U.S. FDA advisors recommend vaccine manufacturers target strains related to JN.1 variant. |
mike kraft |
|
Group Post |
U.S. CDC reports multiple cases of new COVID variant linked to surge in China |
mike kraft |
|
Group Post |
RFK Jr's U.S. health report report targets food, drug, tech industries: Key takeaways |
mike kraft |
|
Group Post |
Global health bodies team up to counter U-S. led funding crisis; China pledges $500M to WHO |
mike kraft |
|
Group Post |
Opinion: Transparency needed in Trump administration's key COVID vaccine decisions |
mike kraft |
|
Group Post |
U.S. FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation |
mike kraft |
|
Group Post |
Vaccines: Moderna pulled back its licensing sbmission for combined flu-COVID shots |
mike kraft |
|
Group Post |
U.S. universities struggle to continue cancer research amid Trump administration budget cuts |
mike kraft |
|
Group Post |
The U.S. hasn't reported a human bird flu case in 3 months. Experts are wondering why |
mike kraft |
|
Group Post |
WHO member states approve 20% funding increase |
mike kraft |
|
Group Post |
Trump administration cuts back on information related to climate change |
mike kraft |
|
Group Post |
Trump administration cuts back CDC distribution of health information about diseases |
mike kraft |
|
Group Post |
U.S.FDA will limit access to Covid-19 boosters for Americans under 65 |
mike kraft |
|
Group Post |
WHO adopts agreement on countering future pandemics but U.S. not involved. |
mike kraft |
|
Group Post |
Overview stats of how measles and other vaccines have saved lives |
mike kraft |
|
Group Post |
Vaccine skepticism a growing concern as Canada records nearly 1600 measles cases |
mike kraft |
|
Group Post |
U.S.measles cases top 1,000 cases, hit 31 states |
mike kraft |
|
Group Post |
WHO grapples with US funding cuts for medical care |
mike kraft |
|
Group Post |
U.S. FDA approves Novavax's COVID-19 vaccine but only for older and high risk people. |
mike kraft |
|
Group Post |
Bird flu his Brazil, triggering trade bans |
mike kraft |
|
Group Post |
Trum administration funding cuts to South Africa will undermine TB and HIV research--analysis |
mike kraft |
|
Group Post |
RFK Jr. clashed with Congressional committee in hearing focusing on vaccines |
mike kraft |
|
Group Post |
A vaccine that protects against swine, human and bird flu could eliminate need for yearly shots -- research |
mike kraft |
|
Group Post |
Some U.S. biotech companies are considering moving clinical trials overseas because of U.S. FDA budget cuts and staff layoffs. |
mike kraft |
Recent Comments